Therefore, this remodeling may be the pathological basis for the deterioration of cardiac function induced by PD-1 inhibitor, potentially leading to reduced cardiac compliance, impaired cardiac function, arrhythmia, heart failure, and sudden cardiac death. Here, PDCD1 is linked to heart failure.